Vertex - About the company
Vertex is an unfunded company based in Hyderabad (India), founded in 1994. It operates as a Provider of residential, commercial, and plotting development services. Vertex has not raised any funding yet. The company has 15720 active competitors, including 208 funded and 1349 that have exited. Its top competitors include companies like Emaar, SILA and M3M India.
Company Details
It is a property development enterprise specializing in residential, commercial, and premium plotting development in Hyderabad and Vijayawada. They offer luxury flats, apartments, villas, and open plots for sale in Hyderabad and Vijayawada.
- Website
- vertexhomes.com
- Registered Address
- PLOT NO 8 & 9, SURVEY NO 66 & 67, VERTEX CORPORATE JUBILEE ENCLAVE, OPP HITEX ENTRANCE, MAD, HAPUR, Hyderabad, HYDERABAD, Telangana, India, 500081
Key Metrics
Founded Year
1994
Location
Hyderabad, India
Stage
Unfunded
Ranked
1665th among 15720 active competitors
Employee Count
308 as on Apr 30, 2026
Similar Companies
Legal entities associated with Vertex
Vertex is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Vertex Klr Developers Llp CIN: AAN-5936 , India, Active | Nov 29, 2018 | - | - | |
VERTEX HOMES PRIVATE LIMITED CIN: U45201TG2000PTC033210 , India, Active | Jan 03, 2000 | $32.3M (As on Mar 31, 2025) | 331 (As on Sep 30, 2024) |
Sign up to download Vertex's company profile
Vertex's funding and investors
Vertex has not raised any funding rounds yet.
Vertex's founders and board of directors
Founder? Claim ProfileVertex's employee count trend
Vertex has 308 employees as of Apr 26. Here is Vertex's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Vertex's Competitors and alternates
Top competitors of Vertex include Emaar, SILA and M3M India. Here is the list of Top 10 competitors of Vertex, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Emaar 1997, Dubai (United Arab Emirates), Public | Provider of real estate development properties | $98M | 76/100 | |
2nd | Provider of facility & project management, advisory, general contracting, and real estate development services | $17.8M | 73/100 | ||
3rd | Provider of real estate and commercial project development services | $538M | 73/100 | ||
4th | Godrej Properties 1990, Mumbai (India), Public | Developer of residential & commercial properties | - | 72/100 | |
5th | Max Estates 2016, Noida (India), Public | Provider of residential & commercial development services | - | - | 68/100 |
6th | Provider of real estate development and management services | - | 68/100 | ||
7th | Marcus& Millichap 1971, Reno (United States), Public | Commercial real estate investment brokerage and capital markets services firm | - | - | 67/100 |
8th | Nagarjuna Construction Company 1978, Hyderabad (India), Public | Provider of commercial property development services | - | 66/100 | |
9th | Howard Hughes 2010, Dallas (United States), Public | Developer of residential & commercial properties | - | 65/100 | |
10th | Developer of residential and commercial properties | - | 65/100 | ||
1665th | Provider of residential, commercial, and plotting development services | - | - | 32/100 |
Looking for more details on Vertex's competitors? Click here to see the top ones
Vertex's Investments and acquisitions
Vertex has made no investments or acquisitions yet.
News related to Vertex
•
•
•
Vertex joins pharma immunotherapy deal uptick with $4.9bn Alpine purchasePharmaceutical Technology•Apr 11, 2024•Vertex Pharmaceuticals, Alpine Immune Sciences, Alpine, Skadden and 2 others
•
VERTIX will invest 60 million euros in housing and buy a hotel in LisbonExpansion•Feb 26, 2024•Vertex
•
anecdotes Raises $25M in Series B FundingFinSMEs•Jan 09, 2024•Anecdotes AI, Glilot Capital Partners, Red Dot Capital Partners, Vintage Investment Partners and 7 others
•
Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta ThalassemiaHerald Chronicle•Nov 16, 2023•CRISPR Therapeutics, Vertex
•
Vertex (NASDAQ:VERX) Given Buy Rating at Needham & Company LLCetfdailynews.com•Aug 12, 2023•Needham, Vertex
•
•
•
Vertex to Acquire ViaCyte for $320 MillionPharmtech•Jul 18, 2022•Vertex, ViaCyte, Vertex Pharmaceuticals
Are you a Founder ?
FAQs about Vertex
Explore our recently published companies
- Capitalsfb.com - 2018 founded, Unfunded company
- Specule - Delhi based, 2017 founded, Unfunded company
- Tech Hive Technologies - Rawalpindi based, 2017 founded, Unfunded company
- Wise Accelerate - Hanoi based, 2021 founded, Unfunded company
- AblyCon Global - Bengaluru based, 2014 founded, Unfunded company
- Civoya - 2025 founded, Unfunded company
